Enrico Papini
Enrico Papini
Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Rome, Italy
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Hervé Monpeyssen
Hervé Monpeyssen
Thyroid Unit, American Hospital, Paris, France
Search for other papers by Hervé Monpeyssen in
Google Scholar
PubMed
Search for other papers by Hervé Monpeyssen in
Google Scholar
PubMed
Andrea Frasoldati
Andrea Frasoldati
Department of Endocrinology and Metabolism, Arcispedale Santa Maria Nuova IRCCS-ASL, Reggio Emilia, Italy
Search for other papers by Andrea Frasoldati in
Google Scholar
PubMed
Search for other papers by Andrea Frasoldati in
Google Scholar
PubMed
Laszlo Hegedüs
Laszlo Hegedüs
Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
devices may differ widely between the different European countries (Table 2 ). Table 2. Modalities, technical characteristics, and estimated costs of thermoablation treatment Radiofrequency An electric field, produced by a
Eduardo Crespo Vallejo
Eduardo Crespo Vallejo
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Eduardo Crespo Vallejo in
Google Scholar
PubMed
Search for other papers by Eduardo Crespo Vallejo in
Google Scholar
PubMed
Antonio Hermosin
Antonio Hermosin
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Antonio Hermosin in
Google Scholar
PubMed
Search for other papers by Antonio Hermosin in
Google Scholar
PubMed
Manuel Gargallo
Manuel Gargallo
Endocrinology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Manuel Gargallo in
Google Scholar
PubMed
Search for other papers by Manuel Gargallo in
Google Scholar
PubMed
Álvaro Villalba
Álvaro Villalba
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Álvaro Villalba in
Google Scholar
PubMed
Search for other papers by Álvaro Villalba in
Google Scholar
PubMed
Eduardo Daguer
Eduardo Daguer
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Eduardo Daguer in
Google Scholar
PubMed
Search for other papers by Eduardo Daguer in
Google Scholar
PubMed
José Flores
José Flores
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by José Flores in
Google Scholar
PubMed
Search for other papers by José Flores in
Google Scholar
PubMed
Javier Periañez
Javier Periañez
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Javier Periañez in
Google Scholar
PubMed
Search for other papers by Javier Periañez in
Google Scholar
PubMed
Joaquim Amorín
Joaquim Amorín
Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain
Search for other papers by Joaquim Amorín in
Google Scholar
PubMed
Search for other papers by Joaquim Amorín in
Google Scholar
PubMed
Ernesto Santos
Ernesto Santos
Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Search for other papers by Ernesto Santos in
Google Scholar
PubMed
Search for other papers by Ernesto Santos in
Google Scholar
PubMed
) causes fewer complications and is more economical compared to surgery ( 7 ). Given the above context, clinicians are compelled to incorporate thermoablation as a preferred therapeutic option in the management of benign TNs. The 2020 European Thyroid
Laura Fugazzola
Laura Fugazzola
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Dagmar Fuhrer
Dagmar Fuhrer
Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Barbara Jarzab
Barbara Jarzab
Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, Villejuif, France
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Kate Newbold
Kate Newbold
Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Jan Smit
Jan Smit
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Jan Smit in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
Thermoablation This procedure is based on the use of electromagnetic waves that induce movement and consequently the production of heat to destroy tumour cells. The technique was initially developed for the treatment of primary and metastatic liver malignancies
Jaume Capdevila
Jaume Capdevila
Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Desiree’ Deandreis
Desiree’ Deandreis
Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Cosimo Durante
Cosimo Durante
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Markus Luster
Markus Luster
Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Romana Netea-Maier
Romana Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Kate Newbold
Kate Newbold
Royal Marsden Hospital, London, United Kingdom
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Susanne Singer
Susanne Singer
Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Gerasimos P Sykiotis
Gerasimos P Sykiotis
Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Beate Bartes
Beate Bartes
Association “Vivre sans Thyroïde”, Léguevin, France
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Kate Farnell
Kate Farnell
Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Laura Deborah Locati
Laura Deborah Locati
Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
) and parallel treatment options for the progressing lesions (e.g. surgery, EBRT, thermoablation etc.). Depending on the tumor’s molecular profile and the regulatory setting in each country, the clinician can consider prescribing a second-line treatment
